Cyp2c29 - cytochrome P450, family 2, subfamily c, polypeptide 29 Gene

Also Known as AHOH; Ah-2; Ahh-1; Cyp2c; AHOHase; P450-2C

Species: Mus musculus

Gene Type: protein coding
Gene ID: 13095

Summary

Enables arachidonic acid 14,15-epoxygenase activity. Involved in arachidonic acid metabolic process. Predicted to be located in endoplasmic reticulum and membrane. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in several structures, including genitourinary system; liver; lung; nervous system; and spleen. Human ortholog(s) of this gene implicated in several diseases, including Plasmodium falciparum malaria; eosinophilic esophagitis; glucose metabolism disease (multiple); invasive aspergillosis; and multiple chemical sensitivity. Orthologous to human CYP2C19 (Cytochrome P450 family 2 subfamily C member 19) and CYP2C9 (Cytochrome P450 family 2 subfamily C member 9). [provided by Alliance of Genome Resources, Apr 2022]

Cyp2c29 Products (4)

mRNA Protein Name
NM_001410153.1 NP_001397082.1 cytochrome P450 2C29 isoform 2 precursor
NM_007815.4 NP_031841.3 cytochrome P450 2C29 isoform 1 precursor
NM_001410153.1 NP_001397082.1 cytochrome P450 2C29 isoform 2 precursor
NM_007815.4 NP_031841.3 cytochrome P450 2C29 isoform 1 precursor

Gene Ontology

  • Molecular Function
  • Biological Process
Molecular Function GO Annotation Evidence References Source
enables arachidonate 14,15-epoxygenase activity IDA
IDA: Inferred from direct assay
9721182 MGI
Biological Process GO Annotation Evidence References Source
involved in arachidonate metabolic process IDA
IDA: Inferred from direct assay
9721182 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

cytochrome P450 2C29

  • CYPIIC29

  • aldehyde oxygenase

  • cytochrome P-450 MUT-2

  • cytochrome P450, 2c29

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-RS03458 CYP2C19 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS03460 CYP2C9 Human Pre-designed siRNA Set A Pre-designed Set / Unkown